DnaJB6 is present in the core of Lewy bodies and is highly up-regulated in parkinsonian astrocytes.

Journal of Neuroscience Research
P F DurrenbergerM B Graeber

Abstract

DnaJ/Hsp40 chaperones determine the activity of Hsp70s by stabilizing their interaction with substrate proteins. We have predicted, based on the in silico analysis of a brain-derived whole-genome transcriptome data set, an increased expression of DnaJ/Hsp40 homologue, subfamily B, member 6 (DnaJB6) in Parkinson's disease (PD; Moran et al. [2006] Neurogenetics 7:1-11). We now show that DnaJB6 is a novel component of Lewy bodies (LBs) in both PD substantia nigra and PD cortex and that it is strongly up-regulated in parkinsonian astrocytes. The presence of DnaJB6 in the center of LBs suggests an early and direct involvement of this chaperone in the neuronal disease process associated with PD. The strong concomitant expression of DnaJB6 in astrocytes emphasizes the involvement of glial cells in PD and could indicate a route for therapeutic intervention. Extracellular alpha-synuclein originating from intravesicular alpha-synuclein is prone to aggregation and the potential source of extracellular aggregates (Lee [2008] J. Mol. Neurosci. 34:17-22). The observed strong expression of DnaJB6 by astrocytes could reflect a protective reaction, so reducing the neuronal release of toxic alpha-synuclein and supporting the astrocyte response i...Continue Reading

References

May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·A HartmannE C Hirsch
Mar 16, 2002·The Journal of Biological Chemistry·Jen-Zen ChuangChing-Hwa Sung
Jan 22, 2003·Acta Neuropathologica·Seishi TeradaShigetoshi Kuroda
Jul 11, 2003·Nucleic Acids Research·Stuart N PeirsonRussell G Foster
Mar 27, 2004·The Journal of Biological Chemistry·Jochen KluckenPamela J McLean
Jul 21, 2004·Lancet Neurology·C Warren OlanowKevin St P McNaught
Jan 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Subramaniam JayanthiJean Lud Cadet
Jun 7, 2005·Current Biology : CB·Britta WesthoffMichael E Cheetham
Jun 10, 2005·Experimental Neurology·Lixia LuAndreas Hartmann
Feb 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Clifford W Shults
Aug 29, 2006·Neurobiology of Disease·Zahra FayaziParsa Kazemi-Esfarjani
Sep 5, 2006·Cellular and Molecular Life Sciences : CMLS·X-B QiuL Wang
Sep 9, 2006·Human Molecular Genetics·Eirene KontopoulosMel B Feany
Sep 16, 2006·Neuropathology and Applied Neurobiology·J Takahashi-Fujigasaki, H Fujigasaki
Jun 29, 2007·Expert Reviews in Molecular Medicine·Jean-Christophe Rochet
Sep 6, 2007·Genes & Development·Cyril BoyaultSaadi Khochbin
Dec 25, 2007·Journal of Molecular Neuroscience : MN·Seung-Jae Lee

❮ Previous
Next ❯

Citations

May 13, 2011·Acta Neuropathologica·Lisa FellnerNadia Stefanova
Jul 30, 2011·Neurogenetics·Gregory J MichaelManuel B Graeber
May 25, 2012·Molecular Neurobiology·Koichi WakabayashiHitoshi Takahashi
Oct 1, 2013·Lancet Neurology·Neshika SamarasekeraJames W Ironside
Oct 5, 2010·Human Molecular Genetics·Johanna M RoseMichael E Cheetham
Jun 15, 2011·Molecular and Cellular Biology·Juhi OjhaAnil G Cashikar
Mar 29, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Herman van der Putten, Gregor P Lotz
Feb 26, 2010·International Journal of Cell Biology·Simone FuldaAfshin Samali
Oct 13, 2014·Clinical Neurology and Neurosurgery·Ichiro YabeHidenao Sasaki
Apr 25, 2013·The Journal of Biological Chemistry·Judith GillisEric A Reits
Apr 17, 2012·Experimental Cell Research·Joel F AndrewsRajeev S Samant
Sep 25, 2009·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Erica D WatsonJames C Cross
Oct 6, 2011·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Erica D WatsonJames C Cross
Feb 16, 2012·Annals of Neurology·Matthew B HarmsRobert H Baloh
Feb 16, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Glenda M Halliday, Claire H Stevens
Sep 17, 2015·Molecular Neurobiology·Amanda M GleixnerRehana K Leak
Aug 15, 2014·Journal of Neural Transmission·Pascal F DurrenbergerRichard Reynolds
Mar 17, 2015·Neurobiology of Aging·Jessica M PosimoRehana K Leak
Jul 30, 2014·Frontiers in Cellular Neuroscience·Carolina Koutras, Janice E A Braun
Sep 12, 2014·Journal of Cell Communication and Signaling·Rehana K Leak
Mar 18, 2011·Neuro-degenerative Diseases·Marie-Pierre HinaultPierre Goloubinoff
Dec 6, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Christina ZarouchliotiMichael E Cheetham
Jun 20, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Aparna MitraRajeev S Samant
Aug 24, 2017·Molecular Pharmacology·Amanda M GleixnerRehana K Leak
Oct 20, 2015·Molecular Neurobiology·Chad Smith, Santosh R D'Mello
Sep 14, 2019·International Journal of Molecular Sciences·Natasja DeshayesChristian Hansen
Jun 9, 2016·Oncotarget·Erhong MengRajeev S Samant
Jul 3, 2019·Frontiers in Cellular Neuroscience·Violetta Refolo, Nadia Stefanova
Aug 24, 2017·Scientific Reports·Francesco A AprileChristian Hansen
Oct 9, 2015·Genetics·Leeanne McGurkNancy M Bonini
Jun 13, 2014·The Journal of Biological Chemistry·Kevin C SteinHeather L True
Jan 11, 2020·Frontiers in Microbiology·Shih-Han KoWoan-Yuh Tarn
Jan 7, 2021·NPJ Genomic Medicine·Muhammad AslamJakob von Engelhardt
Aug 3, 2021·Journal of Parkinson's Disease·Jonas FolkeChristian Hansen
Aug 15, 2021·Neurobiology of Disease·Sertan ArkanChristian Hansen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.